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The General Prognosis of Patients
With Peripheral Arterial Disease Differs
According to the Disease Localization
Victor Aboyans, MD, PHD,*† Ileana Desormais, MD,* Philippe Lacroix, MD,*† Johanna Salazar, MD,*
Michael H. Criqui, MD, MPH,‡ Marc Laskar, MD*
Limoges, France; and La Jolla, California
Objectives The purpose of this study was to assess the general prognosis of patients with peripheral arterial disease (PAD)
according to the disease localization.
Background PAD is associated with poor cardiovascular disease prognosis. However, it is unknown whether the general prog-
nosis could differ according to PAD topography.
Methods Data for all patients who underwent a first digital subtraction angiography of their lower limbs between Jan-
uary 2000 and December 2005 at our hospital were reviewed. Arterial stenoses 50% were located by 2
experienced vascular physicians. The following events were collected until April 2007: death, nonfatal myo-
cardial infarction or stroke, and coronary or carotid revascularization. The primary outcome combined all
these events.
Results We studied 400 PAD patients (age 68.3  12.3 years, 77.5% men). Aortoiliac disease (proximal PAD) and in-
frailiac disease (distal PAD) were noted in 211 (52.8%) and 344 (86.0%) cases, respectively. Male sex and
smoking were more prevalent in proximal PAD, whereas older age, diabetes, hypertension, and renal failure
were more prevalent in distal PAD (p  0.05). During the follow-up period (34  23 months), the event-free sur-
vival curves differed according to the PAD localization (p  0.03). Adjusted for age, sex, cardiovascular disease
history and cardiovascular disease risk factors, critical leg ischemia status, and treatments, proximal PAD was
significantly associated with a worse prognosis (primary outcome hazard ratio: 3.28; death hazard ratio: 3.18,
p  0.002 vs. distal PAD).
Conclusions This is the first study to report a poorer general prognosis of patients with proximal (aortoiliac) PAD compared
with those with more distal PAD, independent of risk factors and comorbidities. (J Am Coll Cardiol 2010;55:
898–903) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.09.055l
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ceripheral arterial disease (PAD) refers to a partial or
omplete obstruction of lower limb arteries due to the
evelopment of atherosclerotic lesions. It includes all local-
zations, from proximal arteries as large as the terminal
bdominal aorta to distal vessels as small as foot arteries.
eyond their sizes, these arteries differ also by their histol-
gy, with a predominance of the elastic components in the
roximal artery media and a progressive predominance of
uscular components of the same layer in more distal
rteries. Similarly, the endothelium possesses different prop-
rties, in part related to variable shear stress according to its
rom the *Department of Thoracic and Cardiovascular Surgery and Vascular
edicine, †EA3174-IFR 175, Limoges University, Limoges, France; and the
Department of Family and Preventive Medicine, University of California, San
iego, La Jolla, California.g
Manuscript received March 30, 2009; revised manuscript received July 22, 2009,
ccepted September 24, 2009.ocation (1). Beyond these histological differences, several
linical/epidemiological studies have already shown that the
evels of sociodemographic and cardiovascular disease
CVD) risk factors associated with PAD differ according to
he localization of the disease (1). Similarly, it was recently
hown that factors affecting the progression of PAD differ
etween large and small vessels (2). It is also well-known
hat distal PAD is associated with more severe limb prog-
osis, especially because revascularization is more difficult
nd not always possible, leading to higher rates of amputa-
ion (3,4).
Regarding the general cardiovascular prognosis, pa-
ients with PAD are overall at higher risk of mortality as
ell as coronary and cerebral ischemic events (5,6). These
ndings led to considering PAD as a high CVD risk
ondition, with the necessity for strict preventive strate-
ies, similar to those proposed for the secondary preven-
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March 2, 2010:898–903 PAD Localization and Prognosision (5,6). However, it is unclear whether the general prog-
osis of PAD patients could differ according to the distribution
f PAD lesions.
We hypothesized that the general prognosis of PAD pa-
ients may differ according to localization, independent of risk
actors and conditions that may be differentially associated with
roximal compared with distal PAD.
ethods
aseline data. We retrospectively reanalyzed all digital
ubtraction angiography (DSA) studies of lower limb arter-
es performed between January 1, 2000, and December 31,
005 in our department for the assessment of PAD. We
nly considered patients who had their first angiography.
atients with any history of lower limb revascularization and
hose who had angiography in the past were excluded from
he study. We also excluded patients hospitalized for the
anagement of nonatherosclerotic diseases (e.g., aneu-
ysms, inflammatory diseases) and those with acute lower
imb ischemia.
All DSA studies were read by 2 senior physicians, and
onsensus was reached in cases of disagreement. For each
imb, these physicians determined the presence/absence of a
50% stenosis in any artery, down to the 3 ankle arteries.
hey were unaware of the patients’ prognosis during the
SA interpretation. The stenoses locations were second-
rily grouped into 3 anatomical levels: aortoiliac arteries,
emoral/popliteal arteries, and infragenicular arteries. Each
atient could have 1 or more levels affected, with coexisting
esions in a same leg or in the other leg. No distinction was
ade regarding the laterality of the lesion (e.g., a patient
ith both femoral/popliteal and infragenicular lesions might
ave the former in 1 leg and the latter in the contralateral
eg, have both lesions in the same leg, or have both legs
ffected by both lesions). Similarly, the extent of the lesions
stenoses length, the number of arteries affected at each
evel) was not considered. After an initial series of analyses
n the 3 arterial levels, aortoiliac, femoral/popliteal, and
nfragenicular arteries, the decision was made to reclassify
esions into 2 patterns due to a similar prognosis in patients
ith the 2 latter localizations of PAD: the proximal lesions
ffecting the abdominal aorta bifurcation and the iliac
rteries and the distal lesions for any localization from the
emoral arteries down to and including the infragenicular
rteries.
The risk factors, comorbidities, and treatments at the
ime of the angiography were collected from the medical
harts, with baseline variables defined as follows: patients
ere considered smokers if they were active smokers ever, at
aseline, or in the past. Diabetes was defined by a fasting
lood glucose7 mmol/l at admission or the use of any oral
ntidiabetic agent and/or insulin. Hyperlipidemia was de-
ned according to the documented patient’s history and/or
fasting blood cholesterol 240 mg/dl at admission.
atients were considered hypertensive if they took any antihypertensive drug for this
urpose and/or if their average
ystolic blood pressure exceeded
40 mm Hg or diastolic blood
ressure exceeded 90 mm Hg
uring the first 2 blood pressure
easurements after admission.
At baseline, several comor-
idities were also taken into ac-
ount: coronary artery disease
as defined according to any documented ischemic episode
eported in the medical chart and/or any history of coronary
evascularization. Heart failure was defined according to the
ocumented medical history and/or the presence of New
ork Heart Association functional class III to IV dyspnea.
erebrovascular disease was defined by any documented
pisode of stroke, transient ischemic attack, or carotid
evascularization. Other conditions listed were the presence
f documented chronic obstructive pulmonary disease and
he presence of renal failure. The latter was defined in cases
f end-stage renal disease with dialysis or a glomerular
ltration rate 60 ml/min/1.73 m2 calculated according to
he MDRD (Modification of Diet in Renal Disease) for-
ula (7). Finally, the PAD clinical status was categorized
ccording to the presence or absence of critical leg ischemia
efined according to the TransAtlantic InterSociety Con-
ensus II criteria (5).
Among baseline therapies, the use of beta-blockers,
tatins, angiotensin-converting enzyme inhibitors or angio-
ensin II antagonists were considered at discharge. We did
ot consider the use of antiplatelet drugs in our analysis
ecause all patients were so treated at discharge, except for
hose who were taking anticoagulation medications for
arious medical reasons (cardiac or vascular diseases) that
ould interfere with the assessment of prognostic factors.
ast, we also included the occurrence of any limb amputa-
ion during the index hospitalization in our baseline data list.
We also performed separate analyses in a subset of
atients whose lesions were limited to 1 of the arterial levels
i.e., only aortoiliac, femoral/popliteal, or infragenicular
esions).
ollow-up data. Patients’ medical charts were systemati-
ally reviewed until April 2007, and follow-up was com-
leted by phone contact with family physicians. Events
oted during follow-up were death, fatal and nonfatal
yocardial infarction or stroke, and coronary or carotid
evascularization. The primary outcome combined these
dverse events.
tatistical analysis. Data are reported as mean (SD) and
umber (percentage) for continuous and categorical vari-
bles, respectively. The Kaplan-Meier survival method was
sed for the comparison of survival according to PAD
ocalization, using the log-rank test. Multivariate analysis
as performed by using a Cox proportional hazards model.
or this purpose, several models were run, by sequentially
Abbreviations
and Acronyms
CVD  cardiovascular
disease
DSA  digital subtraction
angiography
PAD  peripheral arterial
diseasedding baseline demographic factors and the presence of
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PAD Localization and Prognosis March 2, 2010:898–903ritical ischemia (model 1), then CVD risk factors (model
), then comorbidities (model 3), and finally treatments
model 4). A p value 0.05 was considered statistically
ignificant. The software used for statistical analysis was
tatview version 5.0 for Windows (SAS Institute, Cary,
orth Carolina).
esults
uring the study period, 843 DSA studies of lower limbs
ere performed on 681 patients. Among them, 400 had
heir first angiography, no acute ischemia at presentation,
nd no history of peripheral revascularization. All had at
east 1 arterial stenosis 50% due to atherosclerotic
esions. We obtained baseline and follow-up data for all
atients. Most patients had several lesions distributed in
ifferent anatomical levels. Approximately one-third of
atients (n  130) had single-level PAD, affecting
Figure 1 Distribution of Arterial
Lesions in the Study Population
tudy Population and Comparisons According to the Presence of PTable 1 Study Population and Comparisons According to the P
Overall
(n  400)
Aortoiliac Disease
Yes (n  211) No (n  189)
Age 68.3 (12.3) 64.7 (12.3)* 72.3 (11.1)
Male sex 310 (77.5) 184 (87.2)* 126 (66.7)
Smoking 252 (63.0) 165 (78.2)* 87 (46.0)
Diabetes 162 (40.5) 66 (31.3)* 96 (50.8)
Dyslipidemia 173 (43.3) 100 (47.4) 73 (38.6)
Hypertension 258 (64.5) 115 (54.5)* 143 (75.7)
Renal failure 95 (24.0) 36 (17.1)† 59 (31.7)
Critical ischemia 264 (66) 121 (57.3)* 143 (75.7)
CAD or CBVD 171 (42.8) 94 (44.6) 77 (40.7)
COPD 73 (18.3) 41 (19.4) 32 (16.9)
Heart failure 71 (17.8) 33 (15.6) 38 (20.1)
Beta-blockers 122 (30.5) 57 (27.0) 65 (34.4)
ACEI/AA2 187 (46.8) 94 (44.6) 93 (49.2)
Statins 188 (47.0) 109 (51.7) 79 (41.8)
Amputation 95 (23.8) 30 (16.6)† 60 (31.8)
p  0.0001. †p  0.001. ‡p  0.05. §p  0.01.
AA2  angiotensin II antagonist; ACEI  angiotensin-converting enzyme inhibitor; CAD  corona
isease; PAD  peripheral arterial disease.xclusively 1 of the 3 anatomical levels (Fig. 1). The
eneral data for our study population are presented in
able 1 as well as comparisons according the presence/
bsence of PAD in the 3 anatomical levels. Patients’
rofiles for aortoiliac PAD differed from those who had
ither femoral/popliteal or infragenicular lesions. Pa-
ients with aortoiliac lesions were overall younger, with
igher proportions of male patients and smokers. Con-
ersely, in patients with more distal lesions, higher rates
f diabetes, hypertension, and renal and heart failure
ere observed. As expected, critical ischemia and ampu-
ations were more frequent in more distal PAD.
Because a majority of patients had several anatomical
evels involved in their disease, 3 separate sets of survival
nalyses were performed, each time according to the pres-
nce or absence of PAD at 1 of the 3 pre-defined levels
Fig. 2). Patients with PAD at the aortoiliac level had
ore CVD events (p  0.01) during follow-up than
atients without aortoiliac disease, whereas similar com-
arisons for the other 2 groups did not show significant
ifferences. Additional analyses on the subset of patients
ho had only 1 anatomical level involved showed simi-
arly poorer prognosis for those with aortoiliac PAD (p 
.04) compared with either of the other 2 groups, which
id not differ significantly from each other (Fig. 3).
verall, it appeared that patients with aortoiliac disease
ad a poorer outcome than other PAD patients. There-
ore, in Figure 4, femoral/popliteal and infragenicular
esions have been combined as the distal PAD group and
ompared with the proximal aortoiliac lesions. For both
verall mortality and cardiovascular events, a poorer
rognosis was noted in cases of proximal PAD. We
ubsequently assessed the association between PAD lo-
alization and prognosis in several multivariate models to
t Each Anatomic Levelce of PAD at Each Anatomic Level
Femoral/Popliteal Disease Infragenicular Disease
Yes (n  311) No (n  89) Yes (n  215) No (n  185)
70.0 (11.5)* 62.4 (13.5) 73.1 (10.1)* 62.9 (12.6)
232 (74.6)† 78 (87.6) 150 (69.7)† 151 (81.6)
187 (60.1)‡ 65 (73.0) 104 (48.4)* 142 (76.8)
132 (42.4) 30 (33.7) 101 (47.0)† 58 (31.4)
126 (40.5) 47 (52.8) 80 (37.2)* 89 (50.6)
213 (68.5)§ 45 (50.6) 153 (71.2)* 99 (53.5)
76 (24.8) 19 (21.4) 68 (31.9)* 24 (13.0)
215 (69.1)‡ 49 (55.1) 159 (74.0)† 101 (54.6)
141 (45.3) 30 (33.7) 92 (42.8) 76 (41.1)
57 (18.3) 16 (18.0) 38 (17.7) 34 (18.4)
55 (17.7) 16 (18.0) 46 (21.4)‡ 24 (13.0)
106 (34.1)§ 16 (18.0) 69 (32.1) 52 (28.1)
155 (49.8)‡ 32 (36.0) 133 (52.6)‡ 70 (37.8)
149 (47.9) 39 (43.8) 89 (41.4)‡ 95 (51.4)
79 (25.4) 16 (18.0) 69 (32.1)* 25 (13.5)AD aresenry artery disease; CBVD  cerebrovascular disease; COPD  chronic obstructive pulmonary
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March 2, 2010:898–903 PAD Localization and Prognosisdjust it to potential confounding variables, such as CVD
isk factors and comorbidities, that were distributed
ifferently in PAD patients according to arteries involved
Table 2). In all models, proximal PAD was significantly
nd substantially associated with mortality as well as with
he occurrence of death or nonfatal CVD events. Regard-
ng distal PAD, we found no significant prognostic
ifferences when femoral/popliteal and infragenicular
esions were studied separately. The multivariate association
etween single-level PAD and CVD events is displayed in
able 3 and shows the increased risk in the aortoiliac group
Figure 2 Comparison of Event-Free
Survival Curves Among PAD Patients
Comparison of event-free survival curves among peripheral arterial disease
(PAD) patients according to the presence/absence of aortoiliac (A), femoral/
popliteal (B), and infragenicular (C) lesions.nd no differences between the other 2 groups.iscussion
n this longitudinal retrospective study, our data confirmed
ur hypothesis that the general prognosis of PAD patients
aries according to the disease localization. Several risk
actors and comorbidities were differentially associated with
roximal and distal PAD, with male sex and smokers more
requent in proximal PAD patients and aging, diabetes,
ypertension, and renal and heart failure more frequent in
istal PAD patients. Among these PAD patients, proximal
AD was found to be independently associated with poorer
urvival and CVD prognosis, even after adjustments for
hese potential confounders.
Several studies have already reported different risk factors
ssociated with PAD according to proximal/distal or large/
mall vessel PAD, although we reached no consensus on
hese topographic definitions (1). In the angiographic stud-
es, proximal arteries usually referred to aortoiliac arteries
Figure 3 Event-Free Survival According to the PAD
Localization in Patients With Single-Level Disease
PAD  peripheral arterial disease.
Figure 4 Event-Free Survival According to PAD Distribution
PAD  peripheral arterial disease.
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PAD Localization and Prognosis March 2, 2010:898–9038–11) or above-knee arteries (12,13). For this reason, we
rst divided pragmatically the anatomical levels into 3
erritories and ultimately decided to fix the lower limit of
roximal PAD at the common femoral artery origin because
he cross-sectional and longitudinal analyses both favored a
imilar pattern for femoral/popliteal and infragenicular le-
ions. Other studies using noninvasive methods to detect
AD defined distal PAD as below-knee (14) arteries and
ven small-vessel PAD as foot arteries (2,15).
Our cross-sectional data regarding the association be-
ween risk factors and PAD localization are consistent with
he earlier reports (2,8–18) Accordingly, several studies
eported more distal PAD in elderly patients (8,10,17,18).
mong traditional risk factors, diabetes has been consis-
ently associated with more distal PAD in several series
8–10,12,13,17), whereas smoking was predominantly as-
ociated with proximal PAD (8–10,13,15,17,18). These
bservations were confirmed by a longitudinal study in
hich smoking was associated with PAD progression in
arge vessels only, whereas diabetes was associated with
isease progression in small vessels only (2). Our data
egarding higher rates of hypertension in distal PAD
onfirm earlier data reported in another angiographic
eries (10).
To our knowledge, this is the first study reporting
ifferent general prognosis in PAD patients according to
heir disease topography, determined by DSA. Using non-
nvasive methods, 2 earlier studies provided prognostic data
n line with our current findings (15,17). In a population
tudy (15), a significant association between mortality and
arge-vessel PAD was reported as opposed to no similar
ssociation in isolated small-vessel (foot arteries) disease. In
hat study, large-vessel PAD involved all arteries above the
nkle. In a vascular clinical study including patients with
nd without PAD, Vogt et al. (17) reported a higher risk of
Association Between Proximal Peripheral ArteriTable 2 Association Between Proximal Peri
Event Model 1 Model 2
All 3.44 (2.10–5.63)* 3.51 (2.11–5
Death 2.65 (1.45–4.83)† 2.87 (1.52–5
Values are hazard ratio (95% confidence interval). In all models, dista
critical ischemia; Model 2  Model 1  smoking, dyslipidemia, diab
disease history, chronic obstructive pulmonary disease, and heart failu
enzyme inhibitors, beta-blockers, statins, and amputations. *p  0.00
Association of Peripheral Arterial Disease LocalCardiovascular Events in Pa ients With a SingleTable 3 Assoc a ion of P pheral Arter al DCardiovascular Events in Patients W
Peripheral Arterial
Disease Location
Model 1
HR (95% CI)
M
HR
Aortoiliac 3.83 (1.73–8.50)* 3.74 (
Femoral/popliteal 1.18 (0.45–2.57) 1.10 (
Infragenicular Reference Re
Values are hazard ratio (95% confidence interval). Model 1 age, sex,
hypertension, and renal failure; Model 3Model 2 cardiovascular di
4  Model 3  angiotensin II antagonists/angiotensin-converting enzyme in
0.005.ortality in patients with aortoiliac and/or femoral/
opliteal disease than in those with infragenicular disease,
djusted for CVD risk factors and comorbidities. The
urrent study permits refining these earlier results and
etermining a significant prognostic difference in patients
ith aortoiliac disease versus those affected by a more distal
attern of PAD. Additionally, the Vogt et al. study (17)
sed segmental blood pressure gradients to determine dis-
ase location. This approach raises the question of an
ccurate assessment of a limb segment distal to a diseased
ne. In our study, the use of DSA, still considered the gold
tandard for PAD assessment, bypassed this issue. In
ddition, our study is the first to assess not only mortality,
ut also nonfatal CVD events. Nonetheless, all 3 studies are
oncordant for a worse general prognosis in (more) proximal
AD.
One might suggest that the differences regarding CVD
vents might be related to acute events during the periop-
rative period because revascularization is more often feasi-
le in cases of proximal PAD. However, the survival and
vent-free curves continue to diverge even several months
fter hospitalization. In contrast, it could be supposed that
igher rates of chronic limb ischemia and amputation might
e associated with a poorer general prognosis in distal PAD.
ur findings do not support this hypothesis. In addition, in
he multivariate models, the association between mortality
r CVD events and proximal PAD persisted even after
djustments to the clinical status, comorbidities, and the use
f major cardiovascular drugs as well as the need for
mputation at baseline.
Looking for any rationale to explain our findings is
hallenging. We did not find any difference regarding the
ssociation between proximal/distal PAD and clinical cor-
nary or cerebrovascular disease. Further, multiple adjust-
ents to control confounders exclude a priori that prognos-
ease and Prognosisl Arterial Disease and Prognosis
Model 3 Model 4
3.60 (2.16–6.02)* 3.28 (1.87–5.75)*
2.91 (1.53–5.53)† 3.18 (1.57–6.46)†
heral arterial disease is used as reference. Model 1  age, sex, and
pertension, and renal failure; Model 3  Model 2  cardiovascular
del 4  Model 3  angiotensin II antagonists/angiotensin-converting
 0.002.
n and Fatal and Nonfatall Disease (n  130)e Loc lization and Fatal and Nonfatal
Single-Level Disease (n  130)
CI)
Model 3
HR (95% CI)
Model 4
HR (95% CI)
.91)† 3.67 (1.55–8.70)* 4.70 (1.65–13.31)*
.50) 1.01 (0.43–2.35) 1.31 (0.52–3.31)
e Reference Reference
ical ischemia; Model 2Model 1 smoking, dyslipidemia, diabetes,
istory, chronic obstructive pulmonary disease, and heart failure; Modelal Disphera
.84)*
.42)†
l perip
etes, hyizatio-Leves as
ith a
odel 2
(95%
1.57–8
0.48–2
ferenc
and crit
sease hhibitors; beta-blockers, statins, and amputations. *p  0.001. †p 
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March 2, 2010:898–903 PAD Localization and Prognosisic differences might be related to different patient risk
rofiles. One hypothesis is that proximal PAD could be
ore strongly associated with central arterial stiffness than
istal PAD. Central arterial stiffness is shown to be a strong
redictor of further coronary events (19). The major limi-
ation of our study is that our patients were at an advanced
tage of their disease. Currently, DSA is limited to severe
AD cases requiring revascularization. Noninvasive tests are
sed before DSA is indicated. The latter is performed only
or considering revascularization strategies in the most
evere cases. This explains why all our patients had at least
arterial stenosis 50%. Consequently, we are unable to
eneralize our findings to patients with less-severe PAD.
ue to its invasive characteristics, DSA can only be per-
ormed in patients with PAD. It is important to point out
hat our study does not suggest a benign prognosis for distal
AD. In fact, the CVD event rate was high in distal PAD,
lthough significantly lower than proximal PAD.
Additional clinical and large-scale epidemiologic studies
re necessary to validate our findings. Nearly all population
tudies to date have used the ankle-brachial index alone to
efine PAD and thus have been unable to define the levels
f diseased arteries. Ultrasonography can now be used as an
maging modality in population studies, although at con-
iderable expense. If our findings were confirmed, this could
esult in additional risk stratification of PAD patients
epending on which lower extremity arteries are affected.
onclusions
mong PAD patients, those with proximal lesions have a
.5- to 3.5-fold risk of mortality and CVD events compared
ith those with distal PAD. This association is independent
f several risk factors and comorbidities, which are differ-
ntially associated with these 2 localizations of PAD. Our
esults contrast with the poorer limb prognosis in cases of
istal PAD. Our finding is limited to hospitalized PAD
atients and needs further confirmation in prospective
opulation studies.
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